Device type · MPA
Endoilluminator
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
MPA
Ophthalmic
Device class
Class II
FDA decisions since 2015
7
510(k), De Novo and PMA
Adverse event reports
17
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Endoilluminator
- Product code
- MPA
- Device class
- Class II
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 876.1500
- Specialty
- Ophthalmology
- FDA record
- Classification database entry for MPA
Latest FDA decisions
K253468 · Decided Aug 10, 2026 · 305 days after receipt
Device type: Endoilluminator (MPA) · GI, Urology & Nephrology
K242184 · Decided Dec 4, 2024 · 132 days after receipt
Device type: Endoilluminator (MPA) · GI, Urology & Nephrology
K233653 · Decided Aug 5, 2024 · 265 days after receipt
Device type: Endoilluminator (MPA) · GI, Urology & Nephrology
4 more FDA decisions with a free account
Reports received
17
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
2
12% of reports
Injury reports
15
88% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 1 | 1 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 5 | 6 | 0 | 0 |
| Jul 24 | 0 | 7 | 0 | 0 |
| Aug 24 | 2 | 6 | 0 | 0 |
| Sep 24 | 5 | 9 | 0 | 0 |
| Oct 24 | 1 | 7 | 0 | 0 |
| Nov 24 | 2 | 4 | 0 | 0 |
| Dec 24 | 0 | 6 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 1 | 2 | 0 | 0 |
| Mar 25 | 1 | 3 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 2 | 0 | 0 |
| Jun 25 | 0 | 1 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 1 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 1 | 0 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 0 | 2 | 0 | 0 |
| Apr 26 | 1 | 1 | 0 | 0 |
| May 26 | 0 | 4 | 0 | 0 |
| Jun 26 | 0 | 1 | 0 | 0 |
| Jul 26 | 0 | 1 | 0 | 0 |
| Aug 26 | 1 | 1 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 2 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Nova Eye14
1 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem14
- Detachment of Device or Device Component1
- Migration1
1 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Eye Injury11
- No Clinical Signs, Symptoms or Conditions3
- Corneal Decompensation1
4 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0307-2026 · Started Aug 5, 2025 · Posted by FDA Oct 24, 2025
Reason given: Due to incomplete seals in the pouch which provide the sterile barrier.
Cause as FDA categorized it: Process control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.